Tardive Dyskinesia

• CLINICAL_TRIALS trial_result · 2009-11-25
  Clinical Trial Update: Piracetam for Treatment Tardive Dyskinesia [Phase 3]

  Phase 3 clinical trial update evaluating piracetam for tardive dyskinesia has completed.

• CLINICAL_TRIALS trial_result · 2009-06-24
  Clinical Trial Update: Tardive Dyskinesia and Cognitive Function [Phase 4]

  Phase 4 clinical trial update from Taipei Veterans General Hospital indicates the study examining tardive dyskinesia and neurocognitive func…

• CLINICAL_TRIALS trial_result · 2009-02-05
  Clinical Trial Update: Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia [Phase 4]

  A Phase 4 study evaluating aripiprazole for neuroleptic-induced tardive dyskinesia is being tracked, with the current trial status listed as…

• CLINICAL_TRIALS trial_result · 2008-05-06
  Clinical Trial Update: Extract of Ginkgo Biloba and Tardive Dyskinesia [Phase 3]

  Phase 3 clinical trial evaluating a Ginkgo biloba extract for tardive dyskinesia (in patients with schizophrenia) has completed.

• CLINICAL_TRIALS trial_result · 2008-02-22
  Clinical Trial Update: Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia [Phase 2]

  Phase 2 clinical trial evaluating the efficacy of docosahexaenoic acid for tardive dyskinesia.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-02-22
  Clinical Trial Update: Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia [Phase 4]

  Phase 4 trial update evaluating risperidone and olanzapine in schizophrenic patients with neuroleptic-induced tardive dyskinesia; study comp…

• CLINICAL_TRIALS trial_result · 2007-05-02
  Clinical Trial Update: The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial [Phase 4]

  Phase 4 trial update evaluating aripiprazole with a focus on monitoring serum prolactin levels over 3 months in schizophrenia and related co…